Patents Represented by Attorney Martin A. Roy
  • Patent number: 6160133
    Abstract: A process for stereoselectively forming N-substituted dihydro-2,3 benzodiazepines which are useful as AMPA receptor antagonists. The process includes an opening reduction step which sets the stereochemistry of the intermediates and the final compounds to the desired enantiomer. The reduction step may be carried out by an enzymatic reduction.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: December 12, 2000
    Assignee: Eli Lilly and Company
    Inventors: David L. Varie, Jeffrey T. Vicenzi, Milton J. Zmijewski